Paul Waring

14.4k citations

62 papers · 2.0k indexed · h-index 26

Impact in

Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cytokine Signaling Pathways and Interactions
- Cancer Diagnosis and Treatment
Pathology and Forensic Medicine top 5%
- Genetic factors in colorectal cancer

Papers in

Oncology 30
- Colorectal Cancer Treatments and Studies 15
- Cytokine Signaling Pathways and Interactions 4
Pathology and Forensic Medicine 14
- Genetic factors in colorectal cancer 10

Co-authors: D Metcalf Joanne Beaver Philip Sutton Arno Müllbacher Jeffrey Presneill Judith E. Layton Victoria Beshay Nicos A. Nicola
Journals: Journal of Clinical Oncology (5 papers)Pathology (3 papers)Australian Journal of Chemistry (3 papers)Histopathology (2 papers)Clinical Colorectal Cancer (2 papers)
Partner nations: Australia United States United Kingdom

In The Last Decade

Paul Waring

61 papers receiving 2.0k citations

Peers

Countries citing papers authored by Paul Waring

Since Specialization

Citations

This map shows the geographic impact of Paul Waring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Waring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Waring more than expected).

Fields of papers citing papers by Paul Waring

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Waring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Waring. The network helps show where Paul Waring may publish in the future.

Co-authors

The 25 scholars most cited alongside Paul Waring, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul Waring Line = papers co-authored together Paul Waring links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Expanded Low Allele Frequency RAS and BRAF V600E Testing in Metastatic Colorectal Cancer as Predictive Biomarkers for Cetuximab in the Randomized CO.17 Trial Clinical Cancer Research ·Jonathan M. Loree, Anthony Dowers, Dongsheng Tu, Derek J. Jonker, Daniel L. Edelstein, Hannah Quinn, Frank Holtrup, Timothy Price, John Zalcberg, Malcolm J. Moore, Christos S. Karapetis, Chris J. O’Callaghan, Paul Waring, Hagen F. Kennecke, Stanley R. Hamilton, Scott Kopetz	2020	19
2	Identification of Pik3ca Mutation as a Genetic Driver of Prostate Cancer That Cooperates with Pten Loss to Accelerate Progression and Castration-Resistant Growth Cancer Discovery ·Helen Pearson, Jason Li, Valérie S. Méniel, Christina M. Fennell, Paul Waring, Karen G. Montgomery, Richard J. Rebello, Arthi A. Macpherson, Sarah Koushyar, Luc Furic, Carleen Cullinane, Richard Clarkson, Matthew J. Smalley, Kaylene J. Simpson, Toby J. Phesse, Peter R. Shepherd, Patrick O. Humbert, Owen J. Sansom, Wayne A. Phillips	2018	78
3	Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study Clinical Colorectal Cancer ·Jeremy Shapiro, Subotheni Thavaneswaran, Craig Underhill, Kristy Robledo, Christos S. Karapetis, Fiona Day, Louise Nott, Michael Jefford, Lorraine A. Chantrill, Nick Pavlakis, Niall C. Tebbutt, Timothy Price, Mustafa Khasraw, Guy A. Van Hazel, Paul Waring, Sabine Tejpar, John Simes, Val Gebski, Jayesh Desai, Eva Segelov	2018	8
4	RAS Mutations as Predictive Biomarkers in Clinical Management of Metastatic Colorectal Cancer Clinical Colorectal Cancer ·Paul Waring, Jeanne Tie, Dipen M. Maru, Christos S. Karapetis	2015	30
5	The Multiple Properties of Gliotoxin and Other Epipolythiodioxopiperazine Metabolites Australian Journal of Chemistry ·Paul Waring, Christina L. L. Chai	2015	6
6	High-Throughput Amplicon-Based Copy Number Detection of 11 Genes in Formalin-Fixed Paraffin-Embedded Ovarian Tumour Samples by MLPA-Seq PLoS ONE ·Olga Kondrashova, Clare J. Love, Sebastian Lunke, Arthur Hsu, (unknown), Paul Waring, Graham R. Taylor	2015	20
7	Immunohistochemistry with the anti-BRAF V600E (VE1) antibody: impact of pre-analytical conditions and concordance with DNA sequencing in colorectal and papillary thyroid carcinoma Pathology ·Katerina Dvorak, Birte Aggeler, John D. Palting, Penny McKelvie, Andrew Ruszkiewicz, Paul Waring	2014	75
8	Physical Education and Blood Lipid Concentrations in Children: The LOOK Randomized Cluster Trial PLoS ONE ·Richard D. Telford, Ross B. Cunningham, Paul Waring, (unknown), (unknown), Lisa Olive, Walter P. Abhayaratna	2013	17
9	Contrasting longitudinal and cross-sectional relationships between insulin resistance and percentage of body fat, fitness, and physical activity in childrenâthe LOOK study Pediatric Diabetes ·Richard D. Telford, Ross B. Cunningham, Jonathan E. Shaw, David W. Dunstan, Antony Lafferty, Graham Reynolds, Peter E. Hickman, Emma Southcott, Julia M. Potter, Paul Waring, Rohan M. Telford	2009	14
10	Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer Familial Cancer ·Maurice B. Loughrey, Paul Waring, Angela Tan, M Trivett, С. Г. Коваленко, Victoria Beshay, Mary‐Anne Young, Grant A. McArthur, Alex Boussioutas, Alexander Dobrovic	2007	131
11	An Expression-Based Site of Origin Diagnostic Method Designed for Clinical Application to Cancer of Unknown Origin Cancer Research ·Richard W. Tothill, Adam Kowalczyk, Danny Rischin, Alex Bousioutas, Izhak Haviv, Ryan K. van Laar, Paul Waring, John Zalcberg, Robyn L. Ward, Andrew V. Biankin, Robert L. Sutherland, Susan M. Henshall, Kwun M. Fong, Jonathan R. Pollack, David D.L. Bowtell, Andrew Holloway	2005	153
12	Resistance to imatinib, low-grade FDG-avidity on PET, and acquired KIT exon 17 mutation in gastrointestinal stromal tumour The Lancet Oncology ·Florian Grimpen, Desmond Yip, Grant A. McArthur, Paul Waring, David Goldstein, Maurice B. Loughrey, Victoria Beshay, Guan C. Chong	2005	30
13	Cerebral relapse of metastatic gastrointestinal stromal tumor during treatment with imatinib mesylate: Case report BMC Cancer ·Brett Hughes, Desmond Yip, David Goldstein, Paul Waring, Victoria Beshay, Guan C. Chong	2004	44
14	Diagnostic application of Epstein–Barr virus-encoded RNA in situ hybridisation Pathology ·Maurice B. Loughrey, Melanie Trivett, Stephen Lade, William K. Murray, Hugh Turner, Paul Waring	2004	14
15	Continuous plasmafiltration in sepsis syndrome Critical Care Medicine ·John H. Reeves, Warwick Butt, Frank Shann, Judith E. Layton, Alastair G. Stewart, Paul Waring, Jeffrey Presneill	1999	156
16	Antitumor Activity of Gold(I), Silver(I) and Copper(I) ComplexesContaining Chiral Tertiary Phosphines Metal-Based Drugs ·Mark J. McKeage, Peter Papathanasiou, Geoffrey Salem, Allan Sjaarda, Gerhard F. Swiegers, Paul Waring, S. Bruce Wild	1998	58
17	Leukemia inhibitory factor levels are elevated in septic shock and various inflammatory body fluids. Journal of Clinical Investigation ·Paul Waring, K Wycherley, Dale Cary, Nicos A. Nicola, D Metcalf	1992	87
18	Fungal warfare in the medicine chest. The New Scientist ·Paul Waring, Arno Müllbacher	1990	3
19	Alloreactive cytotoxic T cells induce DNA fragmentation in peritoneal macrophages: evidence for target cell killing by cytotoxic T cells in vivo European Journal of Immunology ·Yang Liu, Paul Waring, Arno Müllbacher	1989	7
20	‘Corkscrew‐like’bacteria associated with gastritis Histopathology ·Paul Waring, Κ.B. Shilkin	1989	11

About Paul Waring

Paul Waring is a scholar working on Oncology, Pathology and Forensic Medicine, Cancer Research, Gastroenterology and Pulmonary and Respiratory Medicine, having authored 62 papers that have together received 2.0k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (15 papers), Genetic factors in colorectal cancer (10 papers), Cancer Genomics and Diagnostics (10 papers), Lung Cancer Treatments and Mutations (9 papers), Immune Response and Inflammation (6 papers), Cytokine Signaling Pathways and Interactions (4 papers), Reproductive System and Pregnancy (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). The work is most often cited by research in Oncology (716 citations), Pathology and Forensic Medicine (356 citations), Immunology (381 citations), Cancer Research (258 citations) and Gastroenterology (65 citations). Paul Waring has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include D Metcalf, Joanne Beaver, Philip Sutton, Arno Müllbacher, Jeffrey Presneill, Judith E. Layton, Victoria Beshay, Nicos A. Nicola, R. J. Watling and Frank Shann. Their work appears in journals such as Journal of Clinical Oncology, Pathology, Australian Journal of Chemistry, Histopathology and Clinical Colorectal Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact